MicroPort CardioFlow Announces Positive Results for Transcatheter Mitral Valve Replacement System
China-based MicroPort Scientific Corp’s spin-off, MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), has announced positive...
Hansoh Pharmaceutical Regains Rights to Ameile After EQRx Partnership Cancellation
Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced the cancellation of its partnership and...
Jumpcan Pharmaceutical Partners with Nanjing Zenshine for Exclusive Promotion Rights of ZX-7101A in China
China-based Jumpcan Pharmaceutical (SHA: 600566) has announced a strategic partnership with fellow Chinese firm Nanjing...
Gilead Sciences Inc. Reports 5% YOY Revenue Increase in Q2 2023 Financials
US-based pharmaceutical major Gilead Sciences Inc., (NASDAQ: GILD) has released its financial results for the...
Amgen Inc. Reports 7% YOY Revenue Increase in Q2 2023 Financials
US-based biotechnology company Amgen Inc., (NASDAQ: AMGN) has released its financial results for the second...
GSK Files Patent Infringement Lawsuit Against Pfizer’s RSV Vaccine Abrysvo
UK pharmaceutical giant GlaxoSmithKline (NYSE: GSK) has taken US-based Pfizer Inc., (NYSE: PFE) to court,...
Novartis AG and Ionis Pharmaceuticals Renew Collaboration on Lp(a)-Driven CVD Drug
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has returned to US-based Ionis Pharmaceuticals Inc., (NASDAQ:...
Grand Pharmaceutical Group Gets NMPA Approval for Generic Eplerenone for Hypertension
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced that it has received marketing approval...
Chia Tai Tianqing Secures Exclusive Rights to InventisBio’s D-1553 in China Licensing Deal
China-based Chia Tai Tianqing has signed a licensing agreement with compatriot firm InventisBio, securing exclusive...
DaVinci Single Port System Launches in Hainan with Successful Surgeries
The DaVinci Single Port robot-assisted surgical system technology has been successfully implemented in Boao, Hainan...
Shanghai’s SMPA Reduces Ceiling Price for Non-Winning Bids in Artificial Joint VBP Tender
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has issued a notification regarding an artificial joint volume-based...
Kunshan Yiyuan Medical Technology Secures Over RMB 100 Million in Series B Financing
Kunshan Yiyuan Medical Technology Co., Ltd (Medical Source), a company in China that specializes in...
HuidaGene Strikes Licensing Deal with Kactus Biosystems for Gene Editing Enzyme hfCas12Max
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced a licensing agreement with fellow Shanghai-based firm...
Novartis China’s Business Growth Lead Zhu Jiakang Departs for Personal Reasons
Swiss pharmaceutical giant Novartis (NYSE: NVS) has seen the departure of Zhu Jiakang, who led...
BeiGene’s Q2 2023 Financial Report Highlights 81.8% YOY Product Revenue Growth
China-based biotech company BeiGene (SHA: 688235, HKG: 6160, NASDAQ: BGNE) has released its financial report...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
Our United Corporation’s Linear Accelerator Approved as Innovative Medical Device by NMPA
Xi’an-based Our United Corporation has announced that its medical electronic linear accelerator has been approved...
CORXEL Gets CDE Approval for Phase III Presbyopia Trials of LNZ100 and LNZ101
Shanghai-based CORXEL, formerly known as Ji Xing Pharmaceuticals, supported by RTW Investments, has announced that...
Lee’s Pharmaceutical Subsidiary Zhaoke Ophthalmology Partners with Eyebright Medical Technology
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered...
BeiGene and Bristol-Myers Squibb/Celgene Settle Partnership, Termination Set for 2023
BeiGene (NASDAQ: BGNE) has announced a settlement and termination agreement with US firm Bristol-Myers Squibb/Celgene...